ACEI associated angioedema: A case study and review

Australian Family Physician

Volumn 40, Issue 12, 2011, Pages 985-988

  Andrew, Nick ^a   Gabb, Genevieve ^a   Del Fante, Matthew ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Angioedema; Angiotensin converting enzyme inhibitors; Drug toxicity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ANGIONEUROTIC EDEMA; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; REVIEW; TONGUE DISEASE; TREATMENT WITHDRAWAL;

AGED; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; TONGUE DISEASES; WITHHOLDING TREATMENT;

EID: 84855944644     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Quincke HI. Uber akutes umschriebenes Hautodem. Monatshefte fur praktische Dermatologie 1882;1:129-31.
2. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 2010;40:50-61.
3. Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol 1980;116:902-5.
4. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260:967-70.
5. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitorinduced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008;100:327-32.
6. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angiooedema. Lancet 1998;351:1693-7.
7. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 2008;51:1624-30.
8. Sica DA, Black HR. Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used? J Clin Hypertens 2002;4:375-80.
9. Grant NN, Deeb ZE, Chia SH. Clinical experience with angiotensin-converting enzyme inhibitorinduced angioedema. Otolaryngol Head Neck Surg 2007;137:931-5.
10. Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 2006;26:725-37.
11. Zingale LC, Beltrami L, Zanichelli A, et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006;175:1065-70.
12. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001;24:599-606.
13. Chiu AG, Newkirk KA, Davidson BJ, Burningham AR, Krowiak EJ, Deeb ZE. Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol 2001;110:834-40.
14. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol 1999;48:861-5.
15. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 1996;26:777-82.
16. Gregory KW, Davis RC. Images in clinical medicine. Angioedema of the intestine. N Engl J Med 1996;334:1641.
17. O udit GY, Dill-Macky MJ, Allard JP. Image of the month. Angiotensin-converting enzyme (ACE) inhibitor angioedema of the intestine. Gastroenterol 2000;119:1190, 424.
18. Oudit G, Girgrah N, Allard J. ACE inhibitor-induced angioedema of the intestine: case report, incidence, pathophysiology, diagnosis and management. Can J Gastroenterol 2001;15:827-32.
19. Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004;17:103-11.
20. Sica DA, Black HR. Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy. Congest Heart Fail 2002;8:334-41, 45.
21. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andren L, Wiholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BM J 1992;304:941-6.
22. Wood SM, Mann RD, Rawlins MD. Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. Br Med J Clin Res Ed 1987;294:91-2.
23. Weiner JM. Failure to recognise the association of life-threatening angio-oedema and angiotensinconverting enzyme inhibitor therapy. Aust N Z J Med 1995;25:241-2.
24. Jones RL, Gabb GM. Angioedema and ACE inhibitors or angiotensin II receptor blockers, revisited. Pharmacoepidemiol Drug Saf 2010;19:S145.
25. Lombardi C, Crivellaro M, Dama A, Senna G, Gargioni S, Passalacqua G. Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors? A questionnaire survey in different medical categories. Chest 2005;128:976-9.
26. Roberts DS, Mahoney EJ, Hutchinson CT, Aliphas A, Grundfast KM. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema. Laryngoscope 2008;118:2115-20.
27. Ortolani C, Bruijnzeel-Koomen C, Bengtsson U, et al. Controversial aspects of adverse reactions to food. European Academy of Allergology and Clinical Immunology (EAACI) Reactions to Food Subcommittee. Allergy 1999;54:27-45.
28. Duan QL, Nikpoor B, Dube MP, et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 2005;77:617-26.
29. Martin JH, Deacon CF, Gorrell MD, Prins JB. Incretin-based therapies: review of the physiology, pharmacology and emerging clinical experience. Intern Med J 2011;41:299-307.
30. Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 2009;54:516-23.
31. Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2006;28:1556-68.
32. Bas M, Greve J, Stelter K, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensinconverting enzyme inhibitors: a case series. Ann Emerg Med 2010;56:278-82.
33. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004;164:910-3.
34. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor associated angioedema. JAMA 1997;278:232-3.